
Hepcludex FDA Approval: First Treatment for Hepatitis D
Review the FDA accelerated approval of Hepcludex (bulevirtide) for chronic hepatitis delta virus (HDV), including clinical trial data and public health impact.
IntuitionLabs is now a member of the Claude Partner Network – AI training and upskilling with Claude for pharma and biotech. Book a call.

Review the FDA accelerated approval of Hepcludex (bulevirtide) for chronic hepatitis delta virus (HDV), including clinical trial data and public health impact.
© 2026 IntuitionLabs. All rights reserved.